Eiger BioPharmaceuticals Inc Shares Near 52-Week Low - Market Mover
The shares closed 1.0% above its 52-week low of $5.07, with trading volume higher than its 30 day average
Dec 30, 2021 by Kwhen Finance Editors
Eiger BioPharmaceuticals Inc (EIGR) shares closed today at 1.0% above its 52 week low of $5.07, giving the company a market cap of $175M. The stock is currently down 57.9% year-to-date, down 50.1% over the past 12 months, and down 52.8% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%.
Trading Activity
- Trading volume this week was 14.7% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Eiger BioPharmaceuticals Inc | -1.0 | -57.9 | -50.1 | -62.1 | 0.8 |
| Dow Jones Industrial Average | 0.2 | 21.0 | 21.8 | -0.3 | 23.9 |
| S&P 500 Index | 0.1 | 29.2 | 29.8 | -0.4 | 32.5 |
| Health Care | 0.6 | 23.0 | 24.6 | -0.8 | 26.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 291.2%
- The company's stock price performance over the past 12 months lags the peer average by 209.1%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Eiger BioPharmaceuticals Inc | EIGR | 0 | -57.9 | -50.1 | -62.1 | 0.8 |
| Peer Avg | N/A | 5.6 | -14.8 | -16.2 | -23.6 | 2.1 |
| National Research Corp | NRC | 29.9 | 0.0 | -4.2 | -23.2 | 8.5 |
| Nymox Pharmaceutical Corp | NYMX | -7.4 | -59.3 | -60.7 | -71.1 | 0 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: